Skip to main content
SpringerLink
Log in

Psychopharmakotherapie im Notarztdienst

  • Chapter
Weiterbildung Notfallmedizin

  • 2202 Accesses

Zusammenfassung

Der zweite Teil des CME-Artikels Psychopharmaka und Psychopharmakotherapie im Notarztdienst setzt sich mit der Pharmakotherapie psychischer Störungen im Notarztdienst auseinander. Im Gegensatz zum Vorgehen bei somatischen Notfällen ist die Pharmakotherapie psychiatrischer Notfälle vielen Notfallmedizinern häufig nicht ausreichend bekannt, obwohl hierfür ebenfalls Leitlinien und Empfehlungen existieren. Im vorliegenden Beitrag werden für die 5 notfallmedizinisch relevanten Syndrome Suizidalität, Delir, psychomotorische Erregungszustände, Stupor und Dissoziation sowie psychopharmakainduzierte Syndrome die aktuellen Therapieempfehlungen, wie sie auch in der demnächst erscheinenden S2-Leitlinie Notfallpsychiatrie beschrieben werden, dargestellt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 29.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Wolf A, Müller MJ, Pajonk FG (2013) Psychopharmaka im Notarztdienst. Notfall Rettungsmed 17 [epub ahead ofprint]

    Google Scholar 

  2. Müller MJ, Lange-Asschenfeldt C (2012) Pharmakotherapie psychiatrischer Notfallsituationen.ln: Gründer G, Benkert 0 (Hrsg) Handbuch der Psychopharmakotherapie. Springer, Berlin Heidelberg New York, S11231135

    Google Scholar 

  3. Flüchter P, Müller V, Pajonk FG (2012) Suizidalität: Procedere im Notfall. Med Klin Intensivmed Notfallmed 107(6):469–475

    Google Scholar 

  4. Deutsche Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde (DGPPN) (2010) Therapeutisehe Maßnahmen bei aggressivem Verhalten in der Psychiatrie und Psychotherapie. AWMF-Leitlinienregisternummer 038/022. AWMF, Düsseldorf. http://www.awmf.org/uploads/tx_szleitlinien/038022_S2_Therapeutische_Massnahmen_beLaggressivem_Verhalten_in_der_Psychiatrie_und_Psychotherapie_lang_08-2009_08-2014.pdf. Zugegriffen: 01.07.2013

    Book  Google Scholar 

  5. Benkert 0, Hippius H (2010) Kompendium der psychiatrischen Pharmakotherapie. Springer, Berlin Heidelberg NewYork

    Google Scholar 

  6. De Fruyt J, Demyttenaere K (2004) Rapid tranquilization: new approaches in the emergency treatment of behavioral disturbanees. Eur Psychiatry 19:243–249

    Article  PubMed  Google Scholar 

  7. Wilson Mp, Pepper, Currier GW et al (2012) The psychopharmacology of agitation: consensus statement of the American Association for Emergency Psychiatry Project Beta PsychopharmacologyWorkgroup. West J Emerg Med 13:26–34

    PubMed  PubMed Central  Google Scholar 

  8. Breier A, Meehan K, Birkett Met al (2002) Adouble-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia. Arch Gen Psychiatry 59:441–448

    Google Scholar 

  9. Citrome L, Volavka J, Czobor Pet al (2006) Efficacy of ziprasidone against hostility in schizophrenia: post hoc analysis of randomized, open-label study data. JClin Psychiatry 67:63864–2

    Google Scholar 

  10. Wright P, Birkett M, David SR et al (2001) Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia. Am J Psychiatry 158:1149–1151

    Article  PubMed  Google Scholar 

  11. Battaglia J, Moss S, Rush Jet al (1997) Haloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective, double-blind, emergency department study. Am J Emerg Med 15:335–340

    Article  PubMed  Google Scholar 

  12. Bieniek SA, Ownby RL, Penalver Aet al (1998) Adouble-blind study oflorazepam versus the combination of haloperidol and lorazepam in managing agitation. Pharmacotherapy 18:57–62

    Google Scholar 

  13. Dorevitch A, Katz N, Zemishlany Zet al (1999) Intramuscularflunitrazepam versus intramuscular haloperidol in the emergency treatment of aggressive psychotic behavior. Am J Psychiatry 156:142–144

    Article  PubMed  Google Scholar 

  14. Foster S, Kessel J, Berman ME et al (1997) Efficacy of lorazepam and haloperidol for rapid tranquilization in a psychiatrie emergency room setting. Int Clin Psychopharmacol 12:175–179

    Google Scholar 

  15. Garza-Trevino ES, Hollister LE, Overall JE et al (1989) Efficacy of combinations of intramuscular antipsychotics and sedative-hypnotics for control of psychotic agitation. Am J Psychiatry 146:1598–1601

    PubMed  Google Scholar 

  16. Wyant M, Diamond BI, O'neal Eet al (1990) The use of midazolam in acutely agitated psychiatrie patients. Psychopharmacol BuIl26:126–129

    Google Scholar 

  17. Huf G, Alexander J, Allen MH (2005) Haloperidol plus promethazine for psychosis induced aggression. Cochrane Database Syst Rev 1:CD00514–6

    Google Scholar 

  18. Huf G, Alexander J, Allen MH et al (2009) Haloperidol plus promethazine for psychosis-induced aggression. Cochrane Database Syst Rev 3:CD00514–6

    Google Scholar 

  19. Satterthwaite TD, Wolf DH, Rosenheck RA et al (2008) Ameta-analysis of the risk of acute extrapyramidal symptoms with intramuscular antipsychotics for the treatment of agitation. JClin Psychiatry 69:1869–1879

    Google Scholar 

  20. Dubin WR, Weiss KJ (1986) Rapid tranquilization: acomparison of thiothixene with loxapine. JClin Psychiatry 47:294–297

    Google Scholar 

  21. Allen MH, Feifel D, Lesem MD et al (2011) Efficacy and safety of loxapine for inhalation in the treatment of agitation in patients with schizophrenia: a randomized, doubleblind, placebo-controlled trial. JClin Psychiatry 72:1313–1321

    Google Scholar 

  22. Kwentus J, Riesenberg RA, Marandi Met al (2012) Rapid acute treatment of agitation in patients with bipolar I disorder: a multicenter, randomized, placebo-controlled c1inical trial with inhaled loxapine. Bipolar Disord 14:31–40

    Google Scholar 

  23. Lesem MD, Tran-Johnson TK, Riesenberg RA et al (2011) Rapid acute treatment of agitation in individuals with schizophrenia: multicentre, randomised, placebo-controlled study of inhaled loxapine. Br JPsychiatry 198:51–58

    Google Scholar 

  24. Citrome L (2011) Aerosolised antipsychotic assuages agitation: inhaled loxapine for agitation associated with schizophrenia or bipolar disorder. lnt JClin Pract 65:330–340

    Google Scholar 

  25. Citrome L (2007) Comparison of intramuscular ziprasidone, olanzapine, or aripiprazole for agitation: aquantitative review of efficacy and safety. JClin Psychiatry 68:1876–1885

    Google Scholar 

  26. Currier GW, Citrome LL, Zimbroff DL et al (2007) Intramuscular aripiprazole in the control of agitation. J Psychiatr Pract 13:159–169

    Article  PubMed  Google Scholar 

  27. Belgamwar RB, Fenton M (2005) Olanzapine IM or velotab for acutely disturbed/agitated people with suspected serious mental illnesses. Cochrane Database Syst Rev 2:CD00372–9

    Google Scholar 

  28. Alexander J, Tharyan P, Adams Cet al (2004) Rapid tranquillisation of violent or agitated patients in a psychiatrie emergency setting. Pragmatic randomised trial of intramuscular 10razepam v. haloperidol plus promethazine. Br J Psychiatry 185:63–69

    Article  PubMed  Google Scholar 

  29. Gillies D, Beck A, Mccloud Aet al (2005) Benzodiazepines alone or in combination with antipsychotic drugs for acute psychosis. Cochrane Database Syst Rev 4:CD00307–9

    Google Scholar 

  30. Zisselman MH, Jaffe RL (2010) ECT in the treatment ofa patient with catatonia: consent and complications. Am J Psychiatry 167:127–132

    PubMed  Google Scholar 

  31. Schmider J, Standhart H, Deuschle Met al (1999) Adouble-blind comparison of lorazepam and oxazepam in psychomotor retardation and mutism. Biol Psychiatry 46:437–441

    Article  PubMed  Google Scholar 

  32. WetzeI H, Heuser I, Benkert 0 (1988) Benzodiazepines for catatonic symptoms, stupor, and mutism. Pharmacopsychiatry 21 :394–395

    Google Scholar 

  33. Aboraya A, Chumber P, Altaha B (2009) The treatment resistant catatonic patient. Curr Psychiatr 8:66–69

    Google Scholar 

  34. Babington PW, Spiegel DR (2007) Treatment of catatonia with olanzapine and amantadine. Psychosomatics 48:534–536

    Article  PubMed  Google Scholar 

  35. Kirino E (2010) Prolonged catatonic stupor successfullytreated with aripiprazole in an adolescent male with schizophrenia: acase report. Clin Schizophr Relat Psychoses 4:18518–8

    Article  Google Scholar 

  36. Peralta V, Campos MS, De Jalon EG et al (2010) DSM-IV catatonia signs and criteria in first-episode, drug-naive, psychotic patients: psychometrie validity and response to antipsychotic medication. Schizophr Res 118:16817–5

    Article  Google Scholar 

  37. Haverkamp W, Deuschle M (2006) Antipsychotikainduzierte QT-Verlangerung. Nervenarzt 77:276, 278280,282–274

    Google Scholar 

  38. JANSSEN-ClLAG GmbH, Neuss (Stand Dezember 2011) Fachinformation Haldol®-Janssen Injektionslösung 5 mg/mI. <http://wwwJachinfo.de>. Zugegriffen 01.07.2013

  39. Arzneimittelkommission der deutschen Ärzteschaft (2010) Drug Safety Mai12010-098 vom 05.05.2010. Arzneimittelkommission der deutschen Ärzteschaft, Berlin

    Google Scholar 

  40. Biedler A, Helfen C, Pajonk FG (2012) Behandlungsbedürftigkeit psychiatrischer Notfälle im Notarztdienst. Evaluierung des "Indikator für psychiatrische Pharmakotherapie". Anaesthesist 61 :116–122

    Article  PubMed  Google Scholar 

  41. Tonn P, Reuter S, Treder Bet al (2004) Die präklinische Behandlung von akut erregten, deliranten oder psychotischen Patienten durch den Notarzt. Notfall Rettungsmed 7:484–492

    Article  Google Scholar 

  42. Brown TM, Skop Bp, Mareth TR (1996) Pathophysiology and management of the serotonin syndrome. Ann Pharmacother 30:527–533

    PubMed  Google Scholar 

  43. Kotlyar M, Dysken M, Adson DE (2005) Update on drug-induced depression in the elderly. Am JGeriatr Pharmacother 3:288–300

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Anästhesiologie, Intensivmedizin und Schmerztherapie, Universitätsklinikum des Saarlandes, Homburg/Saar, Homburg/Saar

    A. Wolf

  2. Vitos Klinikum Gießen-Marburg, Gießen

    MJ. Müller

  3. Klinik für Psychiatrie und Psychotherapie, Georg-August-Universität Göttingen, Göttingen

    F,-G.B. Pajonk

Authors
  1. A. Wolf
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. MJ. Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F,-G.B. Pajonk
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik für Anästhesiologie, Universitätsklinikum Ulm, 89070, Ulm

    B. Dirks

  2. Interdisziplinäre Rettungsstelle, Uni. med. Berlin, Berlin

    R. Somasundaram

  3. Klinik und Poliklinik für Unfallchirurgie, Universitätsklinikum Essen, Hufelandstraße 55, 45122, Essen

    C. Waydhas

  4. Medizinische Klinik B, Klinikum Ludwigshafen, Bremserstraße 79, 67063, Ludwigshafen

    U. Zeymer

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Wolf, A., Müller, M., Pajonk, FG. (2015). Psychopharmakotherapie im Notarztdienst. In: Dirks, B., Somasundaram, R., Waydhas, C., Zeymer, U. (eds) Weiterbildung Notfallmedizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-46523-3_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-46523-3_2

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-46522-6

  • Online ISBN: 978-3-662-46523-3

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation